Swiss National Bank
TXG icon

Swiss National Bank’s 10x Genomics TXG Stock Holding History

Swiss National Bank’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.15M Buy
212,600
+5,200
+3% +$136K ﹤0.01% 1153
2026
Q1 		$4.4M Buy
207,400
+4,400
+2% +$88K ﹤0.01% 1435
2025
Q4 		$3.31M Buy
203,000
+9,200
+5% +$139K ﹤0.01% 1597
2025
Q3 		$2.27M Buy
193,800
+7,300
+4% +$95.2K ﹤0.01% 1799
2025
Q2 		$2.16M Hold
186,500
– – ﹤0.01% 1768
2025
Q1 		$1.63M Sell
186,500
-1,900
-1% -$24K ﹤0.01% 1885
2024
Q4 		$2.71M Buy
188,400
+2,700
+1% +$42.6K ﹤0.01% 1683
2024
Q3 		$4.19M Sell
185,700
-1,400
-0.7% -$28.9K ﹤0.01% 1436
2024
Q2 		$3.64M Buy
187,100
+12,400
+7% +$325K ﹤0.01% 1466
2024
Q1 		$6.56M Buy
174,700
+1,500
+0.9% +$65.9K ﹤0.01% 1126
2023
Q4 		$9.69M Sell
173,200
-10,200
-6% -$444K 0.01% 905
2023
Q3 		$7.57M Sell
183,400
-6,900
-4% -$359K 0.01% 1036
2023
Q2 		$10.6M Buy
190,300
+25,200
+15% +$1.36M 0.01% 875
2023
Q1 		$9.21M Sell
165,100
-18,500
-10% -$864K 0.01% 918
2022
Q4 		$6.69M Sell
183,600
-16,900
-8% -$553K ﹤0.01% 1133
2022
Q3 		$5.71M Buy
200,500
+2,500
+1% +$95.2K ﹤0.01% 1198
2022
Q2 		$8.96M Sell
198,000
-139,224
-41% -$7.22M 0.01% 977
2022
Q1 		$25.7M Buy
337,224
+44,600
+15% +$3.9M 0.01% 630
2021
Q4 		$43.6M Sell
292,624
-600
-0.2% -$91.9K 0.03% 531
2021
Q3 		$42.7M Sell
293,224
-5,100
-2% -$876K 0.03% 530
2021
Q2 		$58.4M Buy
298,324
+51,724
+21% +$9.36M 0.04% 463
2021
Q1 		$44.6M Buy
246,600
+14,700
+6% +$2.54M 0.03% 521
2020
Q4 		$32.8M Buy
+231,900
New +$33.7M 0.02% 551

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Swiss National Bank's TXG Position: Q2 2026 in Review

Swiss National Bank increased its 10x Genomics (TXG) stake by 2.5% in Q2 2026, buying an estimated $136K and bringing the position to 212,600 shares worth $8.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1153.

Swiss National Bank first reported a position in TXG in Q4 2020 and has held it in 23 quarters since. The position peaked at $58.4M in Q2 2021. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Swiss National Bank held 212,600 shares of 10x Genomics worth $8.15M as of Q2 2026.
  • Swiss National Bank bought 5,200 10x Genomics shares in Q2 2026, an estimated $136K.
  • 10x Genomics made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1153 holding.
  • Swiss National Bank first reported a position in 10x Genomics in Q4 2020 and has held it in 23 quarters since.
  • Swiss National Bank's 10x Genomics position peaked at $58.4M in Q2 2021.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.